# Oramed Pharmaceuticals Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 10-K/A
- Filed: 2025-07-16
- Accepted by EDGAR: Jul 16, 2025, 20:05 ET
- Period: 2024-12-31
- Accession: 0001213900-25-064678
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025064678/ea0248993-10ka1_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390025064678/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390025064678/ea0248993-10ka1_oramed.htm

Filed Jul 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-064678. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.